421 related articles for article (PubMed ID: 10796266)
1. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
2. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Bahadue FL; Soll R
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
[TBL] [Abstract][Full Text] [Related]
3. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
4. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
6. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
7. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
Gortner L
J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
[TBL] [Abstract][Full Text] [Related]
8. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
9. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
Wiseman LR; Bryson HM
Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
[TBL] [Abstract][Full Text] [Related]
10. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
Lancet; 1992 Dec; 340(8832):1363-9. PubMed ID: 1360087
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
[TBL] [Abstract][Full Text] [Related]
12. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
13. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Osborn DA
Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428
[TBL] [Abstract][Full Text] [Related]
14. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
15. Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants.
Bhuta T; Henderson-Smart DJ
Cochrane Database Syst Rev; 2000; 1998(2):CD000438. PubMed ID: 10796364
[TBL] [Abstract][Full Text] [Related]
16. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Corbet A; Bucciarelli R; Goldman S; Mammel M; Wold D; Long W
J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates.
Sabzevari F; Eslamian M; Karami Robati F; Bahmanbijari B; Daei Parizi Z; Jamali Z
BMC Pediatr; 2023 Dec; 23(1):608. PubMed ID: 38036980
[TBL] [Abstract][Full Text] [Related]
19. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
